Patents by Inventor David Morton

David Morton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12186361
    Abstract: This invention relates to drug delivery and in particular to the delivery of biologically active agents in the form of dry powders for inhalation. The invention also relates to methods for preparing such dry powder formulations and methods for their use.
    Type: Grant
    Filed: June 15, 2021
    Date of Patent: January 7, 2025
    Assignee: Monash University
    Inventors: Michelle McIntosh, David Morton, Tomas Sou, Livesey Olerile, Richard Prankerd
  • Publication number: 20220152145
    Abstract: This invention relates to drug delivery and in particular to the delivery of biologically active agents in the form of dry powders for inhalation. The invention also relates to methods for preparing such dry powder formulations and methods for their use.
    Type: Application
    Filed: June 15, 2021
    Publication date: May 19, 2022
    Inventors: Michelle McIntosh, David Morton, Tomas Sou, Livesey Olerile, Richard Prankerd
  • Patent number: 11103448
    Abstract: The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: August 31, 2021
    Assignee: VECTURA LIMITED
    Inventors: David Morton, John Staniforth
  • Patent number: 11065297
    Abstract: This invention relates to drug delivery and in particular to the delivery of biologically active agents in the form of dry powders for inhalation. The invention also relates to methods for preparing such dry powder formulations and methods for their use.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: July 20, 2021
    Assignee: MONASH UNIVERSITY
    Inventors: Michelle McIntosh, David Morton, Tomas Sou, Livesey Olerile, Richard Prankerd
  • Patent number: 10857169
    Abstract: Powder formulations for inhalation which comprise microparticles containing an antibiotic and magnesium stearate are useful for the treatment of bacterial infections associated with certain pulmonary diseases.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: December 8, 2020
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: David Morton, Qi Zhou, Rossella Musa
  • Patent number: 10733044
    Abstract: The present disclosure relates to processing operations that enable use of cache memory for content validation and error remediation of content. Functionality of the cache is extended to enable interfacing between a cache and a validation component, which is configured to validate data read directly from the cache. Corrupted content may be updated and propagated to a permanent data store associated with an application/service, system, etc. Use of the cache may be optimal for targeting recent and/or heavily accessed content as well as a means for offloading data processing operations from a permanent data storage. Examples described herein extend to those in which data associated with an electronic file is already stored in cache memory as well as those in which update occurs directly to a permanent data storage and subsequently forwarded for validation processing.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: August 4, 2020
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Sameeksha Subhedar, David Morton
  • Patent number: 10653632
    Abstract: The present disclosure relates generally to binder powders for use in powder material processing and processes for their preparation. The disclosure further relates to binder powders for use in making solid powder compact forms, solid powder compact forms containing said binder powders and methods for making solid powder compact forms.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: May 19, 2020
    Assignee: Monash University
    Inventors: David Morton, Laurence Orlando, Tony Qi Zhou, Louise Chia-Hua Ho
  • Publication number: 20200012553
    Abstract: The present disclosure relates to processing operations that enable use of cache memory for content validation and error remediation of content. Functionality of the cache is extended to enable interfacing between a cache and a validation component, which is configured to validate data read directly from the cache. Corrupted content may be updated and propagated to a permanent data store associated with an application/service, system, etc. Use of the cache may be optimal for targeting recent and/or heavily accessed content as well as a means for offloading data processing operations from a permanent data storage. Examples described herein extend to those in which data associated with an electronic file is already stored in cache memory as well as those in which update occurs directly to a permanent data storage and subsequently forwarded for validation processing.
    Type: Application
    Filed: July 9, 2018
    Publication date: January 9, 2020
    Inventors: Sameeksha Subhedar, David Morton
  • Publication number: 20180177721
    Abstract: The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.
    Type: Application
    Filed: February 23, 2018
    Publication date: June 28, 2018
    Inventors: DAVID MORTON, JOHN STANIFORTH
  • Patent number: 9889097
    Abstract: The invention relates to a novel powder, it's method of manufacture and the use thereof in powder material processing, particularly in the manufacture of components formed from compacted powder e.g. discs, monoliths, layers or tablets. The powders comprise coated host particles wherein over 70% of the mass of the powder comprises coated particles smaller than 100 microns. The powders have particular application in the pharmaceutical industry and the technology described can be used to control the properties of active pharmaceutical ingredients. The powders (10) may comprise drug particles (12), carrier particles (14) and additives (16).
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: February 13, 2018
    Assignee: NANO4M LIMITED
    Inventor: David Morton
  • Publication number: 20170224762
    Abstract: This invention relates to drug delivery and in particular to the delivery of biologically active agents in the form of dry powders for inhalation. The invention also relates to methods for preparing such dry powder formulations and methods for their use.
    Type: Application
    Filed: November 4, 2016
    Publication date: August 10, 2017
    Inventors: Michelle MCINTOSH, David MORTON, Tomas SOU, Livesey OLERILE, Richard PRANKERD
  • Publication number: 20170216203
    Abstract: The present invention is concerned with a refinement of the processing of particles that are to form a dry powder formulation which is to be administered to the lung using a dry powder inhaler (DPI) device. In particular, the present invention provides the processing of particles of active material and particles of carrier material in the presence of additive material to provide a powder composition which exhibits excellent powder properties and which is economical to produce.
    Type: Application
    Filed: April 10, 2017
    Publication date: August 3, 2017
    Inventor: DAVID MORTON
  • Patent number: 9642800
    Abstract: The present invention is concerned with a refinement of the processing of particles that are to form a dry powder formulation which is to be administered to the lung using a dry powder inhaler (DPI) device. In particular, the present invention provides the processing of particles of active material and particles of carrier material in the presence of additive material to provide a powder composition which exhibits excellent powder properties and which is economical to produce.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: May 9, 2017
    Assignee: VECTURA LIMITED
    Inventor: David Morton
  • Patent number: 9585834
    Abstract: The present invention is concerned with a refinement of the processing of particles that are to form a dry powder formulation which is to be administered to the lung using a dry powder inhaler (DPI) device. In particular, the present invention provides the processing of particles of active material and particles of carrier material in the presence of additive material to provide a powder composition which exhibits excellent powder properties and which is economical to produce.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: March 7, 2017
    Assignee: VECTURA LIMITED
    Inventor: David Morton
  • Publication number: 20160158150
    Abstract: The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.
    Type: Application
    Filed: December 15, 2015
    Publication date: June 9, 2016
    Inventors: DAVID MORTON, JOHN STANIFORTH
  • Publication number: 20160000709
    Abstract: The present invention is concerned with a refinement of the processing of particles that are to form a dry powder formulation which is to be administered to the lung using a dry powder inhaler (DPI) device. In particular, the present invention provides the processing of particles of active material and particles of carrier material in the presence of additive material to provide a powder composition which exhibits excellent powder properties and which is economical to produce.
    Type: Application
    Filed: August 11, 2015
    Publication date: January 7, 2016
    Inventor: DAVID MORTON
  • Publication number: 20150291188
    Abstract: An infill balise is arranged upstream of a route component in the direction of travel. The infill balise receives information relating to a state of the route component, and the control of a rail vehicle is carried out by taking into account the state of the route component. Since the infill balise is positioned ahead of the route component, the rail vehicle can still react in good time to the state of the route component and, initiate a braking or an acceleration process. This reduces the delay and increases the safety as well as the efficiency in the railway mode, in particular if the route component lying ahead is located at the start of an area which is controlled by another interlock box. The infill balise is used instead of a block interface. This is advantageous because the implementation of block interfaces is challenging, complicated and costly.
    Type: Application
    Filed: September 11, 2013
    Publication date: October 15, 2015
    Inventor: David Morton
  • Publication number: 20150225003
    Abstract: An infill balise is provided for making available a state of a route component (for example of a signal) which lies ahead in the direction of travel of a rail line. Depending on a state of the route component, the infill balise brings about a change of the European train control system (ETCS) mode of a rail vehicle if the rail vehicle is in a manual travel mode or is not in a monitored travel mode. The presented solution has the advantage that the infill balise can ensure safety even in a manual ETCS mode (for example a staff responsible mode or an on-site mode). The solution can preferably be used in conjunction with ETCS level 1 applications.
    Type: Application
    Filed: September 10, 2013
    Publication date: August 13, 2015
    Inventor: David Morton
  • Patent number: D930354
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: September 14, 2021
    Assignee: Magswitch Technology Worldwide PTY LTD.
    Inventors: David Morton, Yiwei Yan
  • Patent number: D1018241
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: March 19, 2024
    Assignee: Magswitch Technology, Inc.
    Inventors: David Morton, Yiwei Yan